Tobacco withdrawal components and their relations with cessation success
Rationale Tobacco withdrawal is a key factor in smoking relapse, but important questions about the withdrawal phenomenon remain. Objectives This research was intended to provide information about two core components of withdrawal (negative affect and craving): (1) how various withdrawal symptom prof...
Gespeichert in:
| Veröffentlicht in: | Psychopharmacologia 2011-08, Vol.216 (4), p.569-578 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 578 |
|---|---|
| container_issue | 4 |
| container_start_page | 569 |
| container_title | Psychopharmacologia |
| container_volume | 216 |
| creator | Piper, Megan E. Schlam, Tanya R. Cook, Jessica W. Sheffer, Megan A. Smith, Stevens S. Loh, Wei-Yin Bolt, Daniel M. Kim, Su-Young Kaye, Jesse T. Hefner, Kathryn R. Baker, Timothy B. |
| description | Rationale
Tobacco withdrawal is a key factor in smoking relapse, but important questions about the withdrawal phenomenon remain.
Objectives
This research was intended to provide information about two core components of withdrawal (negative affect and craving): (1) how various withdrawal symptom profile dimensions (e.g., mean level, volatility, extreme values) differ between negative affect and craving; and (2) how these dimensions relate to cessation outcome.
Methods
Adult smokers (
N
= 1,504) in a double-blind randomized placebo-controlled smoking cessation trial provided real-time withdrawal symptom data four times per day for 4 weeks (2 weeks pre-quit and 2 weeks post-quit) via palmtop computers. Cessation outcome was biochemically confirmed 8-week point-prevalence abstinence.
Results
Examination of craving and negative affect dimensions following a cessation attempt revealed that craving symptoms differed from negative affect symptoms, with higher means, greater variability, and a greater incidence of extreme peaks. Regression analyses revealed that abstinence was associated with lower mean levels of both craving and negative affect and fewer incidences of extreme craving peaks. In a multivariate model, the increase in mean craving and negative affect scores each uniquely predicted relapse.
Conclusions
Real-time reports revealed different patterns of abstinence-related negative affect and craving and that dimensions of both predict cessation outcome, suggesting that negative affect and craving dimensions each has motivational significance. This underscores the complexity of withdrawal as a determinant of relapse and the need to measure its distinct components and dimensions. |
| doi_str_mv | 10.1007/s00213-011-2250-3 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A353752703</galeid><sourcerecordid>A353752703</sourcerecordid><originalsourceid>FETCH-LOGICAL-c597t-6bda6dbe4074694c3a97f861eca4e3066eaeac6e864003806cfd909ac01fe2cf3</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0EotvCD-CCIlDFKWX8kTi5IFUVUKRKXMrZmnUmu66y9mInVPx7nGZpKQL7YI3nmdeeeRl7xeGMA-j3CUBwWQLnpRAVlPIJW3ElRSlAi6dsBSBlKXnVHLHjlG4gL9Wo5-xIcMVrIdWKXV6HNVobils3bruItzgUNuz2wZMfU4G-K8YtuVhEGnB0wac7srCU0l1cpMnOwQv2rMch0cvDecK-ffp4fXFZXn39_OXi_Kq0VavHsl53WHdrUqBV3SorsdV9U3OyqEhCXRMS2pqaWuXfN1DbvmuhRQu8J2F7ecI-LLr7ab2jzuZvRhzMProdxp8moDOPM95tzSb8MJLLVmuVBd4dBGL4PlEazc4lS8OAnsKUTNNIUEK0MpNv_iJvwhR97i5DoHUFDc_Q2wXa4EDG-T7kV-0sac5lJXUlNMxSZ_-g8u5o52wedu_y_aMCvhTYGFKK1N93yMHM5pvFfJPNN7P5Zq55_edo7it-u52B0wOAyeLQR_TWpQdOyUYJPvckFi7llN9QfGj8_6__Aixixow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>880775081</pqid></control><display><type>article</type><title>Tobacco withdrawal components and their relations with cessation success</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Piper, Megan E. ; Schlam, Tanya R. ; Cook, Jessica W. ; Sheffer, Megan A. ; Smith, Stevens S. ; Loh, Wei-Yin ; Bolt, Daniel M. ; Kim, Su-Young ; Kaye, Jesse T. ; Hefner, Kathryn R. ; Baker, Timothy B.</creator><creatorcontrib>Piper, Megan E. ; Schlam, Tanya R. ; Cook, Jessica W. ; Sheffer, Megan A. ; Smith, Stevens S. ; Loh, Wei-Yin ; Bolt, Daniel M. ; Kim, Su-Young ; Kaye, Jesse T. ; Hefner, Kathryn R. ; Baker, Timothy B.</creatorcontrib><description>Rationale
Tobacco withdrawal is a key factor in smoking relapse, but important questions about the withdrawal phenomenon remain.
Objectives
This research was intended to provide information about two core components of withdrawal (negative affect and craving): (1) how various withdrawal symptom profile dimensions (e.g., mean level, volatility, extreme values) differ between negative affect and craving; and (2) how these dimensions relate to cessation outcome.
Methods
Adult smokers (
N
= 1,504) in a double-blind randomized placebo-controlled smoking cessation trial provided real-time withdrawal symptom data four times per day for 4 weeks (2 weeks pre-quit and 2 weeks post-quit) via palmtop computers. Cessation outcome was biochemically confirmed 8-week point-prevalence abstinence.
Results
Examination of craving and negative affect dimensions following a cessation attempt revealed that craving symptoms differed from negative affect symptoms, with higher means, greater variability, and a greater incidence of extreme peaks. Regression analyses revealed that abstinence was associated with lower mean levels of both craving and negative affect and fewer incidences of extreme craving peaks. In a multivariate model, the increase in mean craving and negative affect scores each uniquely predicted relapse.
Conclusions
Real-time reports revealed different patterns of abstinence-related negative affect and craving and that dimensions of both predict cessation outcome, suggesting that negative affect and craving dimensions each has motivational significance. This underscores the complexity of withdrawal as a determinant of relapse and the need to measure its distinct components and dimensions.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-011-2250-3</identifier><identifier>PMID: 21416234</identifier><identifier>CODEN: PSYPAG</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Addictive behaviors ; Adult ; Adult and adolescent clinical studies ; Affect ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Bupropion - administration & dosage ; Bupropion - therapeutic use ; Double-Blind Method ; Drug addiction ; Hand-held computers ; Hand-held terminals ; Humans ; Medical sciences ; Multivariate Analysis ; Neurosciences ; Nicotine ; Nicotine - administration & dosage ; Nicotine - therapeutic use ; Nicotinic Agonists - administration & dosage ; Nicotinic Agonists - therapeutic use ; Original Investigation ; Pharmacology/Toxicology ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Recurrence ; Regression Analysis ; Smokers ; Smoking cessation ; Smoking Cessation - methods ; Substance Withdrawal Syndrome ; Tobacco smoking ; Tobacco Use Disorder - rehabilitation ; Tobacco, tobacco smoking ; Toxicology ; Treatment Outcome</subject><ispartof>Psychopharmacologia, 2011-08, Vol.216 (4), p.569-578</ispartof><rights>Springer-Verlag 2011</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2011 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c597t-6bda6dbe4074694c3a97f861eca4e3066eaeac6e864003806cfd909ac01fe2cf3</citedby><cites>FETCH-LOGICAL-c597t-6bda6dbe4074694c3a97f861eca4e3066eaeac6e864003806cfd909ac01fe2cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00213-011-2250-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00213-011-2250-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24384211$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21416234$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piper, Megan E.</creatorcontrib><creatorcontrib>Schlam, Tanya R.</creatorcontrib><creatorcontrib>Cook, Jessica W.</creatorcontrib><creatorcontrib>Sheffer, Megan A.</creatorcontrib><creatorcontrib>Smith, Stevens S.</creatorcontrib><creatorcontrib>Loh, Wei-Yin</creatorcontrib><creatorcontrib>Bolt, Daniel M.</creatorcontrib><creatorcontrib>Kim, Su-Young</creatorcontrib><creatorcontrib>Kaye, Jesse T.</creatorcontrib><creatorcontrib>Hefner, Kathryn R.</creatorcontrib><creatorcontrib>Baker, Timothy B.</creatorcontrib><title>Tobacco withdrawal components and their relations with cessation success</title><title>Psychopharmacologia</title><addtitle>Psychopharmacology</addtitle><addtitle>Psychopharmacology (Berl)</addtitle><description>Rationale
Tobacco withdrawal is a key factor in smoking relapse, but important questions about the withdrawal phenomenon remain.
Objectives
This research was intended to provide information about two core components of withdrawal (negative affect and craving): (1) how various withdrawal symptom profile dimensions (e.g., mean level, volatility, extreme values) differ between negative affect and craving; and (2) how these dimensions relate to cessation outcome.
Methods
Adult smokers (
N
= 1,504) in a double-blind randomized placebo-controlled smoking cessation trial provided real-time withdrawal symptom data four times per day for 4 weeks (2 weeks pre-quit and 2 weeks post-quit) via palmtop computers. Cessation outcome was biochemically confirmed 8-week point-prevalence abstinence.
Results
Examination of craving and negative affect dimensions following a cessation attempt revealed that craving symptoms differed from negative affect symptoms, with higher means, greater variability, and a greater incidence of extreme peaks. Regression analyses revealed that abstinence was associated with lower mean levels of both craving and negative affect and fewer incidences of extreme craving peaks. In a multivariate model, the increase in mean craving and negative affect scores each uniquely predicted relapse.
Conclusions
Real-time reports revealed different patterns of abstinence-related negative affect and craving and that dimensions of both predict cessation outcome, suggesting that negative affect and craving dimensions each has motivational significance. This underscores the complexity of withdrawal as a determinant of relapse and the need to measure its distinct components and dimensions.</description><subject>Addictive behaviors</subject><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Affect</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bupropion - administration & dosage</subject><subject>Bupropion - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Drug addiction</subject><subject>Hand-held computers</subject><subject>Hand-held terminals</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Multivariate Analysis</subject><subject>Neurosciences</subject><subject>Nicotine</subject><subject>Nicotine - administration & dosage</subject><subject>Nicotine - therapeutic use</subject><subject>Nicotinic Agonists - administration & dosage</subject><subject>Nicotinic Agonists - therapeutic use</subject><subject>Original Investigation</subject><subject>Pharmacology/Toxicology</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Recurrence</subject><subject>Regression Analysis</subject><subject>Smokers</subject><subject>Smoking cessation</subject><subject>Smoking Cessation - methods</subject><subject>Substance Withdrawal Syndrome</subject><subject>Tobacco smoking</subject><subject>Tobacco Use Disorder - rehabilitation</subject><subject>Tobacco, tobacco smoking</subject><subject>Toxicology</subject><subject>Treatment Outcome</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU1v1DAQhi0EotvCD-CCIlDFKWX8kTi5IFUVUKRKXMrZmnUmu66y9mInVPx7nGZpKQL7YI3nmdeeeRl7xeGMA-j3CUBwWQLnpRAVlPIJW3ElRSlAi6dsBSBlKXnVHLHjlG4gL9Wo5-xIcMVrIdWKXV6HNVobils3bruItzgUNuz2wZMfU4G-K8YtuVhEGnB0wac7srCU0l1cpMnOwQv2rMch0cvDecK-ffp4fXFZXn39_OXi_Kq0VavHsl53WHdrUqBV3SorsdV9U3OyqEhCXRMS2pqaWuXfN1DbvmuhRQu8J2F7ecI-LLr7ab2jzuZvRhzMProdxp8moDOPM95tzSb8MJLLVmuVBd4dBGL4PlEazc4lS8OAnsKUTNNIUEK0MpNv_iJvwhR97i5DoHUFDc_Q2wXa4EDG-T7kV-0sac5lJXUlNMxSZ_-g8u5o52wedu_y_aMCvhTYGFKK1N93yMHM5pvFfJPNN7P5Zq55_edo7it-u52B0wOAyeLQR_TWpQdOyUYJPvckFi7llN9QfGj8_6__Aixixow</recordid><startdate>20110801</startdate><enddate>20110801</enddate><creator>Piper, Megan E.</creator><creator>Schlam, Tanya R.</creator><creator>Cook, Jessica W.</creator><creator>Sheffer, Megan A.</creator><creator>Smith, Stevens S.</creator><creator>Loh, Wei-Yin</creator><creator>Bolt, Daniel M.</creator><creator>Kim, Su-Young</creator><creator>Kaye, Jesse T.</creator><creator>Hefner, Kathryn R.</creator><creator>Baker, Timothy B.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20110801</creationdate><title>Tobacco withdrawal components and their relations with cessation success</title><author>Piper, Megan E. ; Schlam, Tanya R. ; Cook, Jessica W. ; Sheffer, Megan A. ; Smith, Stevens S. ; Loh, Wei-Yin ; Bolt, Daniel M. ; Kim, Su-Young ; Kaye, Jesse T. ; Hefner, Kathryn R. ; Baker, Timothy B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c597t-6bda6dbe4074694c3a97f861eca4e3066eaeac6e864003806cfd909ac01fe2cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Addictive behaviors</topic><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Affect</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bupropion - administration & dosage</topic><topic>Bupropion - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Drug addiction</topic><topic>Hand-held computers</topic><topic>Hand-held terminals</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Multivariate Analysis</topic><topic>Neurosciences</topic><topic>Nicotine</topic><topic>Nicotine - administration & dosage</topic><topic>Nicotine - therapeutic use</topic><topic>Nicotinic Agonists - administration & dosage</topic><topic>Nicotinic Agonists - therapeutic use</topic><topic>Original Investigation</topic><topic>Pharmacology/Toxicology</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Recurrence</topic><topic>Regression Analysis</topic><topic>Smokers</topic><topic>Smoking cessation</topic><topic>Smoking Cessation - methods</topic><topic>Substance Withdrawal Syndrome</topic><topic>Tobacco smoking</topic><topic>Tobacco Use Disorder - rehabilitation</topic><topic>Tobacco, tobacco smoking</topic><topic>Toxicology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piper, Megan E.</creatorcontrib><creatorcontrib>Schlam, Tanya R.</creatorcontrib><creatorcontrib>Cook, Jessica W.</creatorcontrib><creatorcontrib>Sheffer, Megan A.</creatorcontrib><creatorcontrib>Smith, Stevens S.</creatorcontrib><creatorcontrib>Loh, Wei-Yin</creatorcontrib><creatorcontrib>Bolt, Daniel M.</creatorcontrib><creatorcontrib>Kim, Su-Young</creatorcontrib><creatorcontrib>Kaye, Jesse T.</creatorcontrib><creatorcontrib>Hefner, Kathryn R.</creatorcontrib><creatorcontrib>Baker, Timothy B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychopharmacologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piper, Megan E.</au><au>Schlam, Tanya R.</au><au>Cook, Jessica W.</au><au>Sheffer, Megan A.</au><au>Smith, Stevens S.</au><au>Loh, Wei-Yin</au><au>Bolt, Daniel M.</au><au>Kim, Su-Young</au><au>Kaye, Jesse T.</au><au>Hefner, Kathryn R.</au><au>Baker, Timothy B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tobacco withdrawal components and their relations with cessation success</atitle><jtitle>Psychopharmacologia</jtitle><stitle>Psychopharmacology</stitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2011-08-01</date><risdate>2011</risdate><volume>216</volume><issue>4</issue><spage>569</spage><epage>578</epage><pages>569-578</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><coden>PSYPAG</coden><abstract>Rationale
Tobacco withdrawal is a key factor in smoking relapse, but important questions about the withdrawal phenomenon remain.
Objectives
This research was intended to provide information about two core components of withdrawal (negative affect and craving): (1) how various withdrawal symptom profile dimensions (e.g., mean level, volatility, extreme values) differ between negative affect and craving; and (2) how these dimensions relate to cessation outcome.
Methods
Adult smokers (
N
= 1,504) in a double-blind randomized placebo-controlled smoking cessation trial provided real-time withdrawal symptom data four times per day for 4 weeks (2 weeks pre-quit and 2 weeks post-quit) via palmtop computers. Cessation outcome was biochemically confirmed 8-week point-prevalence abstinence.
Results
Examination of craving and negative affect dimensions following a cessation attempt revealed that craving symptoms differed from negative affect symptoms, with higher means, greater variability, and a greater incidence of extreme peaks. Regression analyses revealed that abstinence was associated with lower mean levels of both craving and negative affect and fewer incidences of extreme craving peaks. In a multivariate model, the increase in mean craving and negative affect scores each uniquely predicted relapse.
Conclusions
Real-time reports revealed different patterns of abstinence-related negative affect and craving and that dimensions of both predict cessation outcome, suggesting that negative affect and craving dimensions each has motivational significance. This underscores the complexity of withdrawal as a determinant of relapse and the need to measure its distinct components and dimensions.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>21416234</pmid><doi>10.1007/s00213-011-2250-3</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0033-3158 |
| ispartof | Psychopharmacologia, 2011-08, Vol.216 (4), p.569-578 |
| issn | 0033-3158 1432-2072 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139774 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Addictive behaviors Adult Adult and adolescent clinical studies Affect Biological and medical sciences Biomedical and Life Sciences Biomedicine Bupropion - administration & dosage Bupropion - therapeutic use Double-Blind Method Drug addiction Hand-held computers Hand-held terminals Humans Medical sciences Multivariate Analysis Neurosciences Nicotine Nicotine - administration & dosage Nicotine - therapeutic use Nicotinic Agonists - administration & dosage Nicotinic Agonists - therapeutic use Original Investigation Pharmacology/Toxicology Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Recurrence Regression Analysis Smokers Smoking cessation Smoking Cessation - methods Substance Withdrawal Syndrome Tobacco smoking Tobacco Use Disorder - rehabilitation Tobacco, tobacco smoking Toxicology Treatment Outcome |
| title | Tobacco withdrawal components and their relations with cessation success |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T14%3A30%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tobacco%20withdrawal%20components%20and%20their%20relations%20with%20cessation%20success&rft.jtitle=Psychopharmacologia&rft.au=Piper,%20Megan%20E.&rft.date=2011-08-01&rft.volume=216&rft.issue=4&rft.spage=569&rft.epage=578&rft.pages=569-578&rft.issn=0033-3158&rft.eissn=1432-2072&rft.coden=PSYPAG&rft_id=info:doi/10.1007/s00213-011-2250-3&rft_dat=%3Cgale_pubme%3EA353752703%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=880775081&rft_id=info:pmid/21416234&rft_galeid=A353752703&rfr_iscdi=true |